We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Eisai Co. Licenses Protein Expression Data Analysis System from Rosetta Biosoftware
News

Eisai Co. Licenses Protein Expression Data Analysis System from Rosetta Biosoftware

Eisai Co. Licenses Protein Expression Data Analysis System from Rosetta Biosoftware
News

Eisai Co. Licenses Protein Expression Data Analysis System from Rosetta Biosoftware

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Eisai Co. Licenses Protein Expression Data Analysis System from Rosetta Biosoftware"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Rosetta Biosoftware announced today that Eisai Co., Ltd. has licensed the Elucidator® system for differential protein expression analysis and biomarker discovery.

Eisai Co. will be using the Elucidator system in the Laboratory of Seeds Finding Technology to support LC-MS quantification methods for identifying potential neurology biomarkers.

“The Elucidator system will be an important tool for enabling quantitative methods and characterizing cancer proteomes by multidimensional LC-MS/MS,” said Yoshiya Oda, Ph.D., senior scientist at the Laboratory of Seeds Finding Technology.

“We are honored to provide the Elucidator system to this prestigious pharmaceutical company,” said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware.

“The Elucidator system supports end-to-end data management and analysis workflow for comparative proteomics, and provides multiple ways for scientists to analyze and refine their data to achieve high-confidence results.”

Advertisement